Hims & Hers Stock Jumps as FDA Reconsiders Restrictions on Copycat Weight-Loss Drugs [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
The change would be a boon for Hims & Hers, which makes copycat weight-loss drugs, and has benefited from the limited availability of some obesity medicines. With Monday's gains, Hims & Hers shares have more than doubled in value since the start of the year. Hims & Hers Health ( HIMS ) shares surged Monday after the Food and Drug Administration (FDA) said compounding pharmacies could continue to produce copycat weight-loss drugs while it reconsiders whether there is a shortage of their active ingredient. The FDA is facing a lawsuit after it ruled earlier this month that Eli Lilly's ( LLY ) popular weight-loss treatments Mounjaro and Zepbound were no longer on its shortages list. The agency allows companies like Hims & Hers to produce compounded copycat drugs when the originals are hard to obtain, allowing them to benefit from the demand for obesity treatments. In a court filing Friday, the FDA said it would not take action against companies that are in violation of its decisi
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- What's Going On With Hims & Hers Health Stock On Wednesday? [Yahoo! Finance]Yahoo! Finance
- Americans Continue to Struggle to Access Branded GLP-1s as Shortages ContinueBusiness Wire
- Hims & Hers Health's (NYSE:HIMS) Strong Earnings Are Of Good Quality [Yahoo! Finance]Yahoo! Finance
- Earnings Estimates Moving Higher for Hims & Hers Health (HIMS): Time to Buy? [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at TD Cowen from $25.00 to $28.00. They now have a "buy" rating on the stock.MarketBeat
HIMS
Earnings
- 11/4/24 - Beat
HIMS
Sec Filings
- 11/13/24 - Form 144
- 11/13/24 - Form 4
- 11/13/24 - Form 4
- HIMS's page on the SEC website